The recruitment period for the TOTO trial study will be extended until March 31, 2025. This decision was made by the Federal Joint Committee (G-BA) in its plenary session on June 20, 2024. The study aims to determine if partial removal of the tonsils can treat recurrent tonsillitis as effectively as complete removal, which is the current standard procedure. Partial removal has the advantage of preserving tonsil tissue for immune defense. If the results show equivalent effectiveness, partial removal could be included as an outpatient service for recurrent tonsillitis under statutory health insurance.
The extended recruitment period aims to compensate for delays caused by the COVID-19 pandemic, which disrupted many clinical trials and studies globally. The pandemic led to restrictions and logistical challenges that made it difficult to recruit and follow up with patients. Extending the recruitment period will allow the study to include more patients and gather sufficient data to make a robust conclusion. This approach is based on an adaptation of the evaluation strategy, considering the latest developments and ensuring that the study meets its goals.
Study Details and Objectives
The TOTO study has been ongoing since 2020 and is being conducted at 25 study centers across Germany. A total of 500 patients, including both adults and children aged 3 and over, are to be included. By mid-June 2024, over 400 patients had already been recruited, with the majority having undergone surgery. The study seeks to explore whether partial removal of the tonsils (tonsillotomy) is as effective in preventing recurrent tonsillitis as complete removal (tonsillectomy). Tonsillotomy could offer significant benefits by preserving some of the tonsil tissue, which plays a role in the body’s immune defense.
The TOTO trial is crucial in the field of otolaryngology as it addresses a common medical procedure with significant implications for patient care. Tonsillectomy is widely performed, particularly in children, but it comes with risks and the potential for postoperative complications. If tonsillotomy proves to be as effective, it could revolutionize the standard treatment protocol for recurrent tonsillitis. Partial removal could reduce the recovery time, lower the risk of complications, and preserve the tonsils’ immunological function, thereby providing a better overall outcome for patients.
Impact on Healthcare Policy
If the study results show that partial tonsil removal is as effective as complete removal, it could lead to significant changes in healthcare policy. The inclusion of tonsillotomy as a reimbursable outpatient service under statutory health insurance would make this less invasive option more accessible to patients. This could result in improved patient satisfaction and outcomes, as well as cost savings for the healthcare system. The findings of the TOTO study will provide the evidence needed to support such policy changes, emphasizing the importance of evidence-based medicine in shaping healthcare practices.
The extension of the TOTO trial reflects a commitment to comprehensive and thorough research. The additional time and increased number of participants will enhance the study’s validity and ensure that the results are applicable to a broad patient population. Hospitals and healthcare providers will have clear guidelines and evidence to follow, which can improve the standard of care for patients with recurrent tonsillitis. This trial’s outcome could set a precedent for how similar studies are conducted and how new medical procedures are evaluated and implemented.
Resource: Gemeinsamer Bundesausschuss, June 27, 2024

This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.